ALZN vs. SAVA
Compare and contrast key facts about Alzamend Neuro, Inc. (ALZN) and Cassava Sciences, Inc. (SAVA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALZN or SAVA.
Key characteristics
ALZN | SAVA | |
---|---|---|
YTD Return | 14.61% | -9.28% |
1Y Return | -84.37% | -12.96% |
Sharpe Ratio | -0.91 | -0.21 |
Daily Std Dev | 93.56% | 72.48% |
Max Drawdown | -99.60% | -99.18% |
Current Drawdown | -99.50% | -84.91% |
Fundamentals
ALZN | SAVA | |
---|---|---|
Market Cap | $7.08M | $856.29M |
EPS | -$2.28 | -$2.32 |
PEG Ratio | 1.17 | 20.44 |
Revenue (TTM) | $0.00 | $0.00 |
Gross Profit (TTM) | $0.00 | -$68.03M |
EBITDA (TTM) | -$15.12M | -$104.43M |
Correlation
The correlation between ALZN and SAVA is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ALZN vs. SAVA - Performance Comparison
In the year-to-date period, ALZN achieves a 14.61% return, which is significantly higher than SAVA's -9.28% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Risk-Adjusted Performance
ALZN vs. SAVA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Alzamend Neuro, Inc. (ALZN) and Cassava Sciences, Inc. (SAVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Alzamend Neuro, Inc. | -0.91 | ||||
Cassava Sciences, Inc. | -0.21 |
Dividends
ALZN vs. SAVA - Dividend Comparison
Neither ALZN nor SAVA has paid dividends to shareholders.
Drawdowns
ALZN vs. SAVA - Drawdown Comparison
The maximum ALZN drawdown since its inception was -99.60%, roughly equal to the maximum SAVA drawdown of -99.18%. The drawdown chart below compares losses from any high point along the way for ALZN and SAVA
Volatility
ALZN vs. SAVA - Volatility Comparison
Alzamend Neuro, Inc. (ALZN) has a higher volatility of 30.11% compared to Cassava Sciences, Inc. (SAVA) at 18.80%. This indicates that ALZN's price experiences larger fluctuations and is considered to be riskier than SAVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.